The Fort Worth Press - US abortion ruling threatens access to arthritis drug

USD -
AED 3.672497
AFN 66.498609
ALL 80.653395
AMD 365.190533
AOA 917.000054
ARS 1498.989302
AUD 1.414597
AWG 1.80125
AZN 1.703622
BAM 1.692154
BBD 2.008721
BDT 123.455081
BHD 0.3761
BIF 2985.970817
BMD 1
BND 1.277984
BOB 11.853211
BRL 5.084798
BSD 0.997309
BTN 94.901089
BWP 13.461555
BYN 2.969692
BYR 19600
BZD 2.005779
CAD 1.394115
CDF 2262.49471
CHF 0.808065
CLF 0.023198
CLP 913.000248
CNY 6.747599
CNH 6.74377
COP 3157.29
CRC 453.361712
CUC 1
CUP 26.5
CVE 95.398565
CZK 20.98875
DJF 177.598394
DKK 6.465797
DOP 58.218911
DZD 132.934044
EGP 49.93801
ERN 15
ETB 160.971007
EUR 0.86491
FJD 2.20855
FKP 0.741752
GBP 0.740515
GEL 2.610163
GGP 0.741752
GHS 11.701051
GIP 0.741752
GMD 73.495368
GNF 8759.111457
GTQ 7.609218
GYD 208.606894
HKD 7.845385
HNL 26.731037
HRK 6.516695
HTG 130.40262
HUF 314.446499
IDR 17763
ILS 2.998355
IMP 0.741752
INR 95.268197
IQD 1306.448752
IRR 1375550.000034
ISK 123.330248
JEP 0.741752
JMD 158.382433
JOD 0.708993
JPY 158.679498
KES 129.360358
KGS 87.449758
KHR 4050.85633
KMF 426.000327
KRW 1418.630255
KWD 0.30887
KYD 0.831109
KZT 467.406398
LAK 22517.541811
LBP 89309.055987
LKR 334.518649
LRD 180.013843
LSL 16.202317
LTL 2.95274
LVL 0.60489
LYD 6.343603
MAD 9.294994
MDL 17.342816
MGA 4255.889809
MKD 53.263787
MMK 2099.549591
MNT 3594.253507
MOP 8.059058
MRU 40.09223
MUR 46.999786
MVR 15.449707
MWK 1729.34998
MXN 17.13935
MYR 4.093046
MZN 63.904995
NAD 16.202107
NGN 1361.210173
NIO 36.701693
NOK 9.513955
NPR 151.845026
NZD 1.695995
OMR 0.3845
PAB 0.997314
PEN 3.377444
PGK 4.407375
PHP 60.743997
PKR 276.877947
PLN 3.722105
PYG 5930.040405
QAR 3.64559
RON 4.529397
RSD 101.489003
RUB 82.645927
RWF 1466.50401
SAR 3.744756
SBD 8.065696
SCR 14.717724
SDG 600.497862
SEK 9.47955
SGD 1.27922
SLE 24.600752
SOS 569.989877
SRD 37.866496
STD 20697.981008
STN 21.197622
SVC 8.726386
SZL 16.199029
THB 32.981035
TJS 9.200175
TMT 3.51
TND 2.92983
TRY 47.717785
TTD 6.759762
TWD 32.242052
TZS 2647.503041
UAH 44.66703
UGX 3714.372216
UYU 40.144833
UZS 11927.514351
VES 755.762395
VND 26167
VUV 119.366412
WST 2.733717
XAF 567.53013
XAG 0.015566
XAU 0.00023
XCD 2.70255
XCG 1.797449
XDR 0.705825
XOF 567.53013
XPF 103.182603
YER 238.398776
ZAR 16.178103
ZMK 9001.203851
ZMW 18.824028
ZWL 321.999592
  • BCC

    2.3400

    86.6

    +2.7%

  • RYCEF

    0.2300

    20.85

    +1.1%

  • GSK

    0.7900

    52.96

    +1.49%

  • RIO

    1.4500

    101.1

    +1.43%

  • RELX

    0.0485

    35.52

    +0.14%

  • AZN

    1.4100

    161.42

    +0.87%

  • RBGPF

    0.7600

    70.5

    +1.08%

  • CMSC

    0.0240

    21.744

    +0.11%

  • NGG

    0.4700

    80.88

    +0.58%

  • BCE

    -0.0200

    22.75

    -0.09%

  • JRI

    0.1500

    12.81

    +1.17%

  • CMSD

    -0.1600

    21.82

    -0.73%

  • BTI

    0.6000

    59.33

    +1.01%

  • BP

    -0.6000

    41.63

    -1.44%

  • VOD

    0.1900

    16.19

    +1.17%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: © POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

T.Harrison--TFWP